1/31/2013

23andMe is asking for saliva samples from any U.S. patient who used Avastin before this year to treat certain metastatic cancers. Study participants will be asked to send a saliva sample and may also submit a blood sample for genetic analysis, and will complete five online surveys throughout the year. The study, called InVite, aims to identify new genetic markers for the diseases and to understand differences in patient response.

Related Summaries